EMA Authorised: Duloxetine Zentiva (duloxetine) — Zentiva, k.s.

View source ↗

Summary

The EMA authorised Duloxetine Zentiva (duloxetine) from Zentiva, k.s. as an approved medicinal product for neuralgia/diabetic neuropathy, major depressive disor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy
• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Duloxetine Zentiva (duloxetine)

Snippet

Status: Authorised. Therapeutic area: Neuralgia;Depressive Disorder, Major;Anxiety Disorders;Diabetes Mellitus. MAH: Zentiva, k.s.. Decision date: 13/03/2024